Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Letolizumab (BMS-986004), a monoclonal antibody directed at CD40L, is engineered to express a mutant IgG1 devoid of effector functions, such as Fc binding and complement fixation. It effectively reduces rejection and thromboembolism while extending survival time [1] [2] [3].
説明 | Letolizumab (BMS-986004), a monoclonal antibody directed at CD40L, is engineered to express a mutant IgG1 devoid of effector functions, such as Fc binding and complement fixation. It effectively reduces rejection and thromboembolism while extending survival time [1] [2] [3]. |
分子量 | N/A |
CAS No. | 1450981-87-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Letolizumab 1450981-87-9 Inhibitor inhibitor inhibit